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Abstract One electron reductions of oxygen and nitrite by
xanthine oxidase form peroxynitrite. The nitrite and oxygen
reducing activities of xanthine oxidase are regulated by oxygen
with Koxygen 26 and 100 WM and Knitrite 1.0 and 1.1 mM with
xanthine and NADH as donor substrates. Optimal peroxynitrite
formation occurs at 70 WM oxygen with purine substrates. Ki-
netic parameters: VmaxV50 nmol/min/mg and Km of 22, 36 and
70 WM for hypoxanthine, pterin and nitrite respectively. Per-
oxynitrite generation is inhibited by allopurinol, superoxide dis-
mutase and diphenylene iodonium. A role for this enzyme activ-
ity can be found in the antibacterial activity of milk and
circulating xanthine oxidase activity.
. 2004 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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1. Introduction
Peroxynitrite has been shown to react with various target
molecules in biologically important systems [1,2]. Formation
occurs from the di¡usion limited reaction of nitric oxide (NO)
and superoxide radicals [3]. Peroxynitrite causes DNA dam-
age [4], enzyme inhibition [5], apoptosis [6] and bacterial tox-
icity [7,8] and has been implicated in various diseases. There-
fore an understanding of the systems most likely to produce
the oxidant is important to determine its role in pathology.
NO can be generated from the NO synthases (NOS), nitrite
disproportionation accelerated by acid conditions [9] and bio-
activation of therapeutic nitrates [10]. Superoxide is formed
from the one electron reduction of oxygen by NADH/
NAD(P)H oxidases [11], xanthine oxidoreductase [12] and
mitochondrial electron transport enzymes [13].
Xanthine oxidase (XO) (EC 1.1.3.22) is a multi-substrate,
multifunctional enzyme. High concentrations are found in
mammalian milk and liver, expressed in the vascular endothe-
lium and measured in the circulation [14^16]. Enzyme expres-
sion is regulated by in£ammatory cytokines, hormones and
oxygen concentration particularly in the endothelium [17].
XO is a molybdenum, £avin, iron^sulphur containing protein
of the mononuclear molybdenum oxygen oxidoreductase fam-
ily [18]. We were the ¢rst to show that the reduction of nitrate
and nitrite by XO in the presence of NADH as reducing
substrate and in the absence of oxygen leads to the production
of NO [19]. However, in the presence of air saturated bu¡er, it
was not possible to measure NO formation unless an inhibitor
of superoxide generation, diphenylene iodonium (DPI), was
included in the reaction [20] and it was postulated that the
competition for available electrons between oxygen and ni-
trate/nitrite caused the loss of NO generating activity. The
enzyme can utilise oxygen and also turnover using alternative
acceptor substrates particularly nitrite.
This investigation has been prompted by the growing liter-
ature on circulating XO and its systemic activities. It is re-
leased into the circulation in liver failure and has been impli-
cated in immunity to trypanosomes in certain animals [21].
Using varied oxygen concentrations, ozone enhanced NO
chemiluminescence and spectrophotometry, the kinetic param-
eters of peroxynitrite formation has been determined. The
micro-environmental conditions under which this activity oc-
curs are important in describing the function of this enzyme in
the circulation.
2. Materials and methods
2.1. Materials
Bovine XO from buttermilk (xanthine:oxygen oxidoreductase, EC
1.1.3.22, 1.4 U/mg) was from Biozyme, UK. Sodium nitrite, hypoxan-
thine, allopurinol, hydrogen peroxide, sodium hydroxide, L-nicotin-
amide adenine dinucleotide reduced form disodium salt (NADH),
diethylenetriaminepentaacetic acid (DTPA), cytochrome c (Cyt c)
from horse heart and dihydrorhodamine-123 (DHR) were from Sig-
ma, UK. DPI was from ICN Biomedicals, USA. Superoxide dismu-
tase (SOD, superoxide:superoxide oxidoreductase, EC 1.15.1.1, 5000
U/mg), from bovine erythrocytes, was from Roche, UK.
2.2. NO measurement
NO was measured as described by Millar et al. [20] using an ozone
enhanced chemiluminescence assay in a continuous £ow apparatus
(Sievers NOA 280). The mean concentration of NO in the ozone
chamber, derived from readings taken every second, is displayed as
parts per billion (ppb), calibrated by using a known concentration of
NO in nitrogen (BOC, UK). The apparatus was modi¢ed to allow a
constant stream of nitrogen, mixed, as necessary, with de¢ned con-
centrations of oxygen to £ow over the surface of a stirred reaction
mixture (1 ml). Peak NO values minus background levels were used,
together with the measured gas £ow rate, to calculate the molar pro-
duction of NO. Oxygen concentrations were varied by blending 100%
oxygen with the nitrogen carrier gas and calculating oxygen concen-
trations from partial pressure measurements and assuming oxygen
solubility in saline as 1.5 WM/Torr [22]. This was con¢rmed using a
calibrated Clark-type oxygen microelectrode (Strathkelvin Instru-
ments, UK).
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2.3. Superoxide measurement
Superoxide generation was measured following the SOD inhibitable
reduction of horse heart Cyt c (40 WM) at 550 nm over time in the
presence or absence of 200 U/ml SOD [23]. This was performed at a
range of oxygen concentrations in a 3 ml stoppered quartz cuvette
adapted to allow mixed gas additions at 37‡C in a spectrophotometer
(Hitachi U-2010, Hitachi, UK) with stirring. Rates were converted to
molarity using an extinction coe⁄cient of 21 000 M31 cm31.
2.4. Urate production
Urate production, from xanthine, was followed spectrophotometri-
cally in a stoppered cuvette at 295 nm using an extinction coe⁄cient
of 1.1U104 M31 cm31 [24].
2.5. NADH oxidation
NADH oxidation was also followed in the same system at 340 nm
using an extinction coe⁄cient of 6.3 mM31 cm31 [25].
2.6. Peroxynitrite measurement
Peroxynitrite generation was measured using the oxidation of DHR
to rhodamine as described by Kooy et al. [26] and Crow [27]. The
absorbance of rhodamine was measured in triplicate at 500 nm using
a 96 well plate format and reader ¢tted with the appropriate ¢lters,
temperature controlled to 37‡C (Anthos Lucy 1, Anthos instruments,
Austria). Using a range of substrates and inhibitors and pregassed
media, in the presence of 100 WM DTPA, kinetic parameters were
calculated from progress curves using the molar extinction coe⁄cient
78 800 M31 cm31 and correcting for the e⁄ciency of oxidation using
authentic peroxynitrite as described [26].
Values are expressed as meanOS.E.M. of at least three repeated
measurements. Kinetic ¢ts to the experimental data were performed
on a PC using GraphPad Prism version 3.02 for Windows (GraphPad
Software, USA).
3. Results
Urate formation, NADH oxidation and superoxide gener-
ation all showed saturation kinetics dependent on the concen-
tration of dissolved oxygen in the reaction mixture (Fig.
1A,B). With xanthine, saturation occurred within the atmo-
spheric range compared to NADH which required oxygen
supersaturation and produced apparent kinetic parameters de-
tailed in Table 1.
In the absence of oxygen, using spectrophotometry, satura-
tion kinetics were observed for nitrite with either NADH or
xanthine as electron donors (Fig. 1C,D and Table 1) respec-
tively. Using ozone chemiluminescence at a range of nitrite
concentrations, the NO generated by XO in the presence of
xanthine and the absence of oxygen was 15, 46 and 112 nmol/
min/mg for 0.1, 0.5 and 1.0 mM nitrite respectively. As the
oxygen concentration was increased in the reaction chamber
the measurable NO signal was reduced for all concentrations
of nitrite until there was no detectable NO signal (Fig. 2A).
At 70 WM oxygen, the e¡ect of superoxide dismutase on
NO generation was measured. SOD addition increased NO
detection in a dose dependent manner that saturated at
around 200 U/ml SOD. Generation of NO in the presence
of SOD was equivalent to 31% of the value obtained in the
absence of oxygen at equimolar concentrations (Fig. 2B). Fur-
ther to this (Fig. 2C) DPI is shown to be an e¡ective inhibitor
of superoxide generation from xanthine and oxygen in air
saturated bu¡er and NO generation at 70 WM oxygen was
increased in a dose dependent manner (Fig. 2D). At concen-
trations of DPI of 400 and 600 WM the NO generated was
103% and 96% of the NO generated in the absence of oxygen
(Fig. 2D).
In accordance with others [28] we noted that NADH had
an inhibitory e¡ect on spontaneous high nitrite mediated
DHR oxidation in a dose dependent manner. Therefore,
NADH was not used in the following experiments. Urate
formation from xanthine is suggested as a scavenger of per-
oxynitrite and initial assays showed this to be the case, there-
fore hypoxanthine or pterin was used as the electron donor
substrate for the following experiments.
Fig. 1. The oxygen dependent superoxide, urate and NADH oxidation by XO. The rates of superoxide (b) formation and NADH (300 WM)
(a) oxidation (A) and superoxide and urate (O) formation (B) from xanthine (20 WM) was determined as described. Rates of NO (F) forma-
tion were also determined in the absence of oxygen and in the presence of varying nitrite concentrations for both NADH (C) and xanthine (D)
as reducing substrates. All reactions were carried out at 37‡C.
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DHR oxidation was elicited from solutions containing ni-
trite, electron donor and enzyme (Fig. 3A) but was not seen
with nitrite alone under the constraints of concentration used
here or in the absence of nitrite. Rates of oxidation were taken
from the progress curves and corrected for the e⁄ciency of
oxidation compared to authentic peroxynitrite. Allopurinol
inhibited DHR oxidation by XO in a dose dependent manner
in a system utilising 20 WM hypoxanthine and 1 mM nitrite
(Fig. 3B) to give an inhibitory concentration IC50 ofV7 WM.
The e¡ect of oxygen concentration on the oxidation of
DHR was pronounced. DHR oxidation was shown to be
greatest at approximately 70^80 WM (Fig. 4A), at high and
low oxygen concentrations, there was little oxidation of DHR.
Kinetic parameters for nitrite, hypoxanthine or pterin at 70
WM oxygen concentration were determined and detailed in
Fig. 4B,C and Table 2. Classic Michaelis^Menten kinetics
are shown for both reducing substrates and nitrite in the pro-
duction of peroxynitrite.
4. Discussion
It is clear that XO can simultaneously reduce oxygen and
nitrite from various reducing and oxidising substrates with the
products going on to form peroxynitrite. Under the conditions
of oxygen concentration used here, rate equations and Km
values can be derived for nitrite and purine substrates at 70
WM oxygen and suggest that these activities may occur most
readily under physiological oxygen concentrations leading to a
de¢ned role for a circulating form of this enzyme.
Nitrite is shown to be an e¡ective electron acceptor sub-
strate for XO and gives comparable Km values to those de-
scribed by Li et al. [29] for both NADH and xanthine as
reducing substrates. However, as oxygen is allowed into the
reaction, NO rates fall to zero. NO reacts rapidly with oxygen
in the gaseous phase at high NO concentrations giving the
characteristic brown fumes of nitrogen dioxide [30] and this
may account for the loss of NO signal in these experiments.
However, in the presence of SOD or DPI, superoxide concen-
trations are reduced allowing the return of the NO signal even
in the presence of oxygen suggesting the reaction of NO and
oxygen in the gaseous phase has minimal e¡ect in this system.
The reaction of NO and molecular oxygen in the aqueous
phase may also have been a confounding factor but has
been reported to be slow with a half-life of several hours
[31]. These results suggest that simultaneous generation of
NO and superoxide occurs over a range of oxygen concentra-
tions with the maximum rates shown at around 70 WM oxy-
gen. From the work of Beckman et al. [32] and Kissner et al.
[3] the reaction of NO and superoxide is shown to be di¡usion
limited and the most likely reaction to occur as shown by the
oxidation of DHR under the conditions described.
Physiological dissolved plasma oxygen concentrations range
Table 1
The kinetic parameter determined for XO derived urate, superoxide, NO and NADH oxidation






Xanthine (20 WM) 26.82O 1.12 193.2O 2.03 ^ 107.9O 0.98 1.039O 0.05 134.4O 3.32 ^ 65.84O 2.04
NADH (300 WM) 102.6O 0.56 374.6O 1.66 227.2O 3.26 ^ 1.182O 0.04 40.12O 2.87 22.31O 1.61 ^
Fig. 2. The e¡ect of oxygen, SOD and DPI on XO generated NO measured by ozone enhanced chemiluminescence. A: NO was generated
from nitrite (1 E, 0.5 F and 0.1 mM a) and XO from xanthine and oxygen. B: The e¡ect of DPI on superoxide (b) and urate (a) formation
from xanthine (20 WM) at 240 WM oxygen in the absence of nitrite is shown. Using 1 mM nitrite and 20 WM xanthine at 70 WM oxygen, SOD
(C) or DPI (D) was added into the reaction mixture and the resultant generated NO (R) was measured as described.
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from 120^135 WM on the arterial side to 55^70 WM on the
venous side [33]. Plasma nitrite can be generated from nitrate
reduction, the reaction of NO with oxygen and Cyt c cata-
lysed formation of nitrite from NO [34,35] and ranges from 10
to 50 WM in normal adults but can rise to 130 WM in patients
with sepsis [36]. This suggests that peroxynitrite formation
from XO can occur under normal physiological concentra-
tions of substrate. Although the proportion of the XO depen-
dent peroxynitrite formation is yet to be determined, evidence
of 3-nitrotyrosine formation in healthy adults of V130 nM
suggests that normal physiological processes can lead to the
formation of peroxynitrite in plasma [37].
A possible problem exists for a functional peroxynitrite
forming enzyme utilising xanthine in the form of the reported
scavenging activity of the product urate. Scavenging of per-
oxynitrite by uric acid has been suggested to decrease peroxy-
nitrite neurotoxicity in diseases such as multiple sclerosis [38].
However, the reaction of peroxynitrite with uric acid has giv-
en con£icting results. Skinner et al. [39] showed that peroxy-
nitrite and uric acid react to give a NO donor species having
downstream e¡ects on vascular relaxation whereas the reac-
tion of peroxynitrite with CO2 was shown to be 920 times
faster than peroxynitrite with uric acid at physiological CO2
concentrations [40]. The picture is further complicated with
peroxynitrite permeation of erythrocytes in the presence of
CO2 [41]. The suggestion is therefore that the simultaneous
formation of uric acid and peroxynitrite by XO does not
Fig. 3. XO derived DHR oxidation to rhodamine and the e¡ect of
allopurinol enzyme activity. A: DHR oxidation, in the presence of
varying nitrite concentrations (i^iv) at 70 WM oxygen, with hypo-
xanthine (20 WM) was measured at 500 nm and 37‡C. B: To this
system allopurinol (b) was added at varying concentrations with
1 mM nitrite and 20 WM hypoxanthine.
Fig. 4. The e¡ect of oxygen and substrate concentration on XO mediated DHR oxidation. A: Using XO, 1 mM nitrite, 20 WM hypoxanthine
at varying oxygen concentrations, the rate of DHR oxidation (b) was measured as described. B: Hypoxanthine at varying concentrations
against varying nitrite concentrations as described at 70 WM oxygen. C: Pterin at varying concentrations against varying nitrite concentrations
as described at 70 WM oxygen.
Table 2
Kinetic parameters derived for the XO dependent formation of per-
oxynitrite
Km (WM) Vmax (nmol/min/mg)
Peroxynitrite
Hypoxanthine 22.35O 0.19 46.11O 1.02
Nitrite 68.91O 3.66
Pterin 36.14O 1.04 29.76O 0.34
Nitrite 40.13O 6.31
Measurements were performed at 70 WM oxygen with varying nitrite
and purine substrates.
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automatically lead to scavenging in physiological environ-
ments due to the competing reactions. Further to these obser-
vations, using NADH as the donor substrate can lead to the
simultaneous reduction of nitrite and oxygen by XO and de-
rive peroxynitrite in the complete absence of purines and ur-
ate.
Circulating plasma XO has been shown to be responsible
for the development of endothelial dysfunction and for remote
organ injury of the lung and intestine after ischaemia^reper-
fusion protocols [42]. We have also shown that XO can bind
to bacterial surface structures and can kill bacteria by the
formation of peroxynitrite both in vitro and in vivo in calves
([2,8], Millar, unpublished results). It is intriguing therefore to
suggest that XO can generate peroxynitrite in the circulation,
at sites systemic to its production and in the neonatal gut as a
¢rst line antibacterial defence mechanism showing a range of
functions both deleterious and bene¢cial. The importance of
the in vivo activity of this enzyme warrants further consider-
ation in the light of these ¢ndings.
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